This gene encodes a key enzyme in catabolism of quinolinate, an intermediate in the tryptophan-nicotinamide adenine dinucleotide pathway. Quinolinate acts as a most potent endogenous exitotoxin to neurons. Elevation of quinolinate levels in the brain has been linked to the pathogenesis of neurodegenerative disorders such as epilepsy, Alzheimer's disease, and Huntington's disease. [provided by RefSeq, Jul 2008].
Thongon, Zucal, DAgostino, Tebaldi, Ravera, Zamporlini, Piacente, Moschoi, Raffaelli, Quattrone, Nencioni, Peyron, Provenzani: "Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA." in: Cancer & metabolism, Vol. 6, pp. 1, (2018) (PubMed).
Hinsch, Frank, Döring, Vorländer, Hansmann: "QPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study." in: BMC cancer, Vol. 9, pp. 93, (2009) (PubMed).
Guillemin, Cullen, Lim, Smythe, Garner, Kapoor, Takikawa, Brew: "Characterization of the kynurenine pathway in human neurons." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 27, Issue 47, pp. 12884-92, (2007) (PubMed).